Papers associated with head region (and kcnh2)

Limit to papers also referencing gene:
Show all head region papers

???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest

Sort Oldest To Newest

	Bioelectric signaling: Reprogrammable circuits underlying embryogenesis, regeneration, and cancer., Levin M., Cell. April 15, 2021;
	Polyunsaturated fatty acid analogues differentially affect cardiac NaV, CaV, and KV channels through unique mechanisms., Bohannon BM., Elife. March 24, 2020; 9
	Fluorescent analogues of BeKm-1 with high and specific activity against the hERG channel., Vasseur L., Toxicon X. February 23, 2019; 2 100010.
	Design and Synthesis of Novel Positive Allosteric Modulators of α7 Nicotinic Acetylcholine Receptors with the Ability To Rescue Auditory Gating Deficit in Mice., Li Y., J Med Chem. January 10, 2019; 62 (1): 159-173.
	VEGFA-dependent and -independent pathways synergise to drive Scl expression and initiate programming of the blood stem cell lineage in Xenopus., Ciau-Uitz A., Development. June 1, 2013; 140 (12): 2632-42.
	Kcnh1 voltage-gated potassium channels are essential for early zebrafish development., Stengel R., J Biol Chem. October 12, 2012; 287 (42): 35565-35575.
	Marine algal toxin azaspiracid is an open-state blocker of hERG potassium channels., Twiner MJ., Chem Res Toxicol. September 17, 2012; 25 (9): 1975-84.
	Sig1R protein regulates hERG channel expression through a post-translational mechanism in leukemic cells., Crottès D., J Biol Chem. August 12, 2011; 286 (32): 27947-58.
	Recombinant expression of the toxic peptide ErgTx1 and role of Met35 on its stability and function., Jimenez-Vargas JM., Peptides. March 1, 2011; 32 (3): 560-7.
	Differential effects of Kv11.1 activators on Kv11.1a, Kv11.1b and Kv11.1a/Kv11.1b channels., Larsen AP., Br J Pharmacol. October 1, 2010; 161 (3): 614-28.
	Synthesis, structural activity-relationships, and biological evaluation of novel amide-based allosteric binding site antagonists in NR1A/NR2B N-methyl-D-aspartate receptors., Mosley CA., Bioorg Med Chem. September 1, 2009; 17 (17): 6463-80.
	Probing the binding sites and mechanisms of action of two human ether-a-go-go-related gene channel activators, 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) and 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD307243)., Xu X., Mol Pharmacol. June 1, 2008; 73 (6): 1709-21.
	Probing the outer mouth structure of the HERG channel with peptide toxin footprinting and molecular modeling., Tseng GN., Biophys J. May 15, 2007; 92 (10): 3524-40.
	[Electrophysiological characterization of long QT syndrome associated mutations V630A and N633S]., She HR., Zhonghua Xin Xue Guan Bing Za Zhi. June 1, 2006; 34 (6): 523-7.
	Effect of S5P alpha-helix charge mutants on inactivation of hERG K+ channels., Clarke CE., J Physiol. June 1, 2006; 573 (Pt 2): 291-304.
	Structure-function studies of the outer mouth and voltage sensor domain of hERG., Tseng GN., Novartis Found Symp. January 1, 2005; 266 19-35; discussion 35-45.
	Gating charges in the activation and inactivation processes of the HERG channel., Zhang M., J Gen Physiol. December 1, 2004; 124 (6): 703-18.
	Structural and functional role of the extracellular s5-p linker in the HERG potassium channel., Liu J., J Gen Physiol. November 1, 2002; 120 (5): 723-37.
	Histidines 578 and 587 in the S5-S6 linker of the human Ether-a-gogo Related Gene-1 K+ channels confer sensitivity to reactive oxygen species., Pannaccione A., J Biol Chem. March 15, 2002; 277 (11): 8912-9.
	[Cardiotoxicity of lindane, a gamma isomer of hexachlorocyclohexane]., Sauviat MP., J Soc Biol. January 1, 2002; 196 (4): 339-48.
	Effects of gallium and mercury ions on transport systems., Moschèn., J Dent Res. August 1, 2001; 80 (8): 1753-7.
	Molecular cloning and expression of cERG, the ether à go-go-related gene from canine myocardium., Zehelein J., Pflugers Arch. May 1, 2001; 442 (2): 188-91.
	Use-dependent 'agonist' effect of azimilide on the HERG channel., Jiang M., J Pharmacol Exp Ther. December 1, 1999; 291 (3): 1324-36.
	Effects of outer mouth mutations on hERG channel function: a comparison with similar mutations in the Shaker channel., Fan JS., Biophys J. June 1, 1999; 76 (6): 3128-40.
	Functional analysis of a mouse brain Elk-type K+ channel., Trudeau MC., J Neurosci. April 15, 1999; 19 (8): 2906-18.
	Regulation of deactivation by an amino terminal domain in human ether-à-go-go-related gene potassium channels., Wang J., J Gen Physiol. November 1, 1998; 112 (5): 637-47.
	Novel mechanism of HERG current suppression in LQT2: shift in voltage dependence of HERG inactivation., Nakajima T., Circ Res. August 24, 1998; 83 (4): 415-22.
	Differential effects of bupivacaine on cardiac K channels: role of channel inactivation and subunit composition in drug-channel interaction., Lipka LJ., J Cardiovasc Electrophysiol. July 1, 1998; 9 (7): 727-42.
	Modulation of HERG affinity for E-4031 by [K+]o and C-type inactivation., Wang S., FEBS Lett. November 3, 1997; 417 (1): 43-7.
	Two isoforms of the mouse ether-a-go-go-related gene coassemble to form channels with properties similar to the rapidly activating component of the cardiac delayed rectifier K+ current., London B., Circ Res. November 1, 1997; 81 (5): 870-8.
	Electrophysiological characterization of an alternatively processed ERG K+ channel in mouse and human hearts., Lees-Miller JP., Circ Res. November 1, 1997; 81 (5): 719-26.
	Tissue and species distribution of mRNA for the IKr-like K+ channel, erg., Wymore RS., Circ Res. February 1, 1997; 80 (2): 261-8.
	Molecular determinants for activation and inactivation of HERG, a human inward rectifier potassium channel., Schönherr R., J Physiol. June 15, 1996; 493 ( Pt 3) 635-42.

???pagination.result.page??? 1